908 Devices Inc. (MASS) earnings date
Mar 2, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 42 days, typically, give or take 11 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Nov 10, 2026 | before open | 41 | 8-K |
| Q2 FY2026 | Tue, Aug 11, 2026 | before open | 42 | 8-K |
| Q1 FY2026 | Wed, May 6, 2026 | before open | 36 | 8-K |
| Q4 FY2025 | Tue, Mar 3, 2026 | before open | 62 | 8-K |
| Q3 FY2025 | Mon, Nov 10, 2025 | before open | 41 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | before open | 36 | 8-K |
| Q1 FY2025 | Tue, May 13, 2025 | before open | 43 | 8-K |
| Q4 FY2024 | Tue, Mar 4, 2025 | before open | 63 | 8-K |
What they guided beta
| Q3 FY2026 | "EX-99.1 2 mass-ex99d1.htm EX-99.1 Exhibit 99.1 908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue Revenue increased 35% compared to prior year Raises low end of 2026 revenue outlook BURLINGTON, Mass. – November 10, 2026 – 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported financial results for the quarter ended September 30, 2026. "We had a strong third quarter, driven by our FTIR portfolio, with revenue gro" exhibit |
| Q3 FY2026 | "Adjusted EBITDA was a loss of $1.7 million for the third quarter of 2026, compared to a loss of $1.8 million for the corresponding period in the prior year. Net loss attributable to common stockholders was $4.6 million for the third quarter of 2026, compared to $15.0 million for the corresponding prior year period. Cash, cash equivalents and marketable securities were $99.1 million as of September 30, 2026, with no debt outstanding. 2026 Guidance 908 Devices updates its full year revenue guidance range to $68.5 million to $70.0 million (from $68.0 million to $70.0 million previously), " exhibit |
| Q2 FY2026 | "EX-99.1 2 mass-20260811xex99d1.htm EX-99.1 Exhibit 99.1 908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook Revenue increased 23% compared to prior year Updated full year 2026 outlook reflects 21% to 25% year-over-year growth BURLINGTON, Mass. – August 11, 2026 – 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported financial results for the quarter ended June 30, 2026. “We delivered another strong" exhibit |
| Q2 FY2026 | "Subsequent to quarter end, secured a $6 million ProtectIR order from a corrections agency in the Asia-Pacific region, further supporting our second-half revenue outlook Second Quarter 2026 Financial Results Revenue was $16.1 million for the three months ended June 30, 2026, a 23% increase over the prior year period, driven by an increase in product revenue for VipIR and the addition of NIRLab revenue." exhibit |
| Q2 FY2026 | "In the second quarter of 2026, $13.5 million of cash and cash equivalents were used for the acquisition of NIRLAB SA and $3.5 million was received from the release of the escrow from the desktop divestiture. 2026 Guidance 908 Devices updates its full year revenue guidance range to $68.0 million to $70.0 million (from $67.0 million to $70.0 million previously), raising the low end of the range and representing 21% to 25% growth compared to 2025 revenue. Webcast Information 908 Devices will host a conference call to discuss the second quarter 2026 financial results before market open on " exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/MASS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/MASS
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/MASS/"><img src="https://veritasdata.dev/embed/MASS.svg" alt="MASS earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/MASS/)
Script
<script async src="https://veritasdata.dev/embed/MASS.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/MASS"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.